APY Therapeutics
PrivateLast Round
Grant
Jul 9, 2025
Total Funding Raised
$51,600
Momentum
Top 50%
of companies Caplight tracks
Company Overview
APY Therapeutics is a biotechnology company developing novel first-in-class arylmyxopyronin-based treatments for drug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
APY Therapeutics Comparables
Compare APY Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| smartbax GmbH | 86% | |
| Kinvard Bio | 84% | |
| Macrolide Pharmaceuticals | 79% | |
APY Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 9, 2025 | ||||
| Grant | Jun 2, 2025 |
APY Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Jersey Commission on Science, Innovation and Technology | Grant |
| INCATE | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
Monthly visitors grew 74% MoM.
- Mar 2, 2026
Monthly visitors increased 52% MoM.
APY Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about APY Therapeutics's valuation, stock price, and market status.